MADDE BAĞIMLILIĞINDA BİREYSEL PSİKOTERAPİ

Khantzian EJ, Khantzian NJ: Cocaine addiction: is there a psychological predisposition? Psychiatric Annals 14:753-759, 1984

Khantzian EJ: The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry 142:1259-1264, 1985

Khantzian EJ, Treece C: DSM- III psychiatric diagnosis of narcotic addicts. Arch Gen Psychiatry 42:1067-1071, 1985

Rounsaville BJ, Weissman MM, Kleber HD, et al: Heterogeneity of psychiatric diagnoses in treated opiate addicts. Arch Gen Psychiatry 39:161-166, 1982

Rounsaville BJ, Foley S, Carroll KM, et al: Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry 48:43-51, 1991.

Weiss RD, Mirin SM, Michael JL, et al: Psychopathology in chronic cocaine abusers. Am J Drug Alcohol Abuse 12:17-29, 1986

Woody GE, Luborsky L, McLellan AT, et al: Psychotherapy for opiate addicts: does it help? Arch Gen Psychiatry 40:639-645, 1983

Woody GE, McLellan AT, O’Brien CP: Research on psychopathology and addiction: treatment implications. Drug Alcohol Depend 25:121-123, 1990

Hanson B, Beschner G, Walters JM: Life With Heroin: Voices from the Inner City. Lexington, MA, DC Heath and Company, 1985

Washton AM: Cocaine Addiction: Treatment, Recovery, and Relapse Prevention. New York, WW Norton, 1989

Khantzian EJ: The primary care therapist and patient needs in substance abuse treatment. Am J Drug Alcohol Abuse 14:159-167, 1987

Stanton MD, Todd TC: The Family Therapy of Drug Abuse and Addiction. New York, Guilford, 1982

Ball JC, Corty E, Petroski SP, et al:Medical services provided to 2394 patients at methadone programs in there states. J Subst Abuse Treat 3:203-209,1986

Pektaş O, Kalyoncu A, Mirsal H, Gooberman LL, Beyazyurek M: Different forms (oral and implant) of naltrexone use in relapse prevention on heroin addicts: a controlled clinical trial up to 6 months follow up (preliminary results). XXI Colllegium Internationale, Neuro-Psycopharmacologicum Congress, July 12-16, 1998, Glosgow, U.K.

Yilmaz S, Kalyoncu A, Mirsal H, Pekta§ O, Serez M, Beyazyurek M: Professional Intervention Meeting. 38th International Congress on Alcohol, Drugs and Other Dependencies, Vienna, Austria, 16-20 August.

Luborsky L, McLellan AT, Woddy GE, et al: Therapist success and its determinants. Arch Gen Psychiatry 42:602-611, 1985

Luborsky L, Crits-Christoph P, McLellan AT: Do therapists vary in their effectiveness? Findings from four outcome studies. Am J Orthopsychiatry 66:501-512, 1986

Kleinman PH, Woody GE, Todd TC, et al: Crack and cocaine abusers in outpatient psychotherapy, in Psychotherapy and Counseling in the Treatment of Drug Abuse, NIDA Res Monogr 104. Edited by Onken LS, Blaine JD. Rockville, MD, Department of Health and Human Services, 1990, pp 24-34

Carroll KM, Rounsaville BJ, Treece FH: A comparative trial of psychotherapies for ambulatory cocaine abusers: relapse prevention and inter-personal psychotherapy. Am J Drug Alcohol Abuse 17:229-247, 1991

LaRosa JC, Lipsius JH, LaRosa JH: Experience with a combination of group therapy and methadone maintenance in the treatment of heroin addiction. Int J Addict 9:605-617, 1974

McLellan AT, Childress AR, Ehrman R, et al: Extinguishing conditioned responses during opiate dependence treatment: turning laboratory findings into clinical procedures. J Subst Abuse Treat 3:33-40, 1986

Resnick RB, Washton AM, Stone- Washton N, et al: Psychotherapy and naltrexone in opioid dependence, in Problems of Drug Dependence, NIDA Res Monogr 34. Edited by Harris LS. Rockville, MD, U.S. Department of Health and Human Services, 1981, pp 109-115

Pektaş Ö, Kalyoncu A, Mırsal H, Pektaş A, Şatır T, Beyazyürek M: Different forms (oral and implant) of naltrexone use in relapse prevention on heroin addicts: a controlled clinical trial up to 6 months follow up. American Academy of Addiction Psychiatry , 10 th Annual Meeting and Symposium, December 2-5, 1999, Nassau Marriott Resort, Nassau, Bahamas.

Kalyoncu A, Pektaş Ö, Mırsal H, Beyazyürek M (1999) Sociodemographic variables and treatment results of the Anatolia clinics inpatients. 38th International Congress on Alcohol, Drugs and Other Dependencies, Vienna, Austria, 16-20 August.

Kalyoncu A, Şatır T, Mırsal H, Pektaş Ö, Beyazyürek M: Naltrexone implant in opiate dependence: sociodemographic variables and evaluation of psychiatric symptoms in the first two months of he first naltrexone implantation. American Academy of Addiction Psychiatry , 10 th Annual Meeting and Symposium, December 2-5, 1999, Nassau Marriott Resort, Nassau, Bahamas.